Kairos Pharma, Ltd. (KAPA) Dividend History

Kairos Pharma, Ltd. (KAPA) is a biotechnology company focused on the development of innovative pharmaceutical therapies. The company specializes in research and development aimed at addressing unmet medical needs through novel drug candidates and delivery systems in various therapeutic areas.

Dividend History

Kairos Pharma, Ltd. currently does not pay dividends

Company News

  • Kairos Pharma Closing of $6.2 Million Initial Public Offering

    Kairos Pharma, a clinical-stage biopharmaceutical company, has closed its $6.2 million initial public offering. The company plans to use the proceeds to fund its Phase 1 and Phase 2 trials for its lead product candidate ENV 105 and advance its preclinical candidate KROS 101.

    Benzinga
Page data last updated 08/19/2025 16:57:14 UTC